Company Quick10K Filing
Argentum 47
10-Q 2020-06-30 Filed 2020-08-10
10-Q 2020-03-31 Filed 2020-05-07
10-K 2019-12-31 Filed 2020-03-25
10-Q 2019-09-30 Filed 2019-11-13
10-Q 2019-06-30 Filed 2019-08-13
10-Q 2019-03-31 Filed 2019-05-10
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-07-25
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-06
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-04
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-03-23
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-11
10-Q 2016-03-31 Filed 2016-05-11
10-K 2015-12-31 Filed 2016-03-18
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-12
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-04-14
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-14
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-13
10-Q 2013-06-30 Filed 2013-08-19
10-Q 2013-03-31 Filed 2013-05-14
10-K 2012-12-31 Filed 2013-04-16
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-06-30 Filed 2012-08-13
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-03-30
8-K 2020-05-22
8-K 2020-02-01
8-K 2019-12-18
8-K 2019-12-13
8-K 2019-12-13
8-K 2019-11-08
8-K 2019-10-09
8-K 2019-06-10
8-K 2019-01-24
8-K 2019-01-14
8-K 2018-08-01
8-K 2018-06-27
8-K 2018-06-06
8-K 2018-03-29
8-K 2018-02-15
8-K 2018-01-17
8-K 2018-01-11

Argentum 47 Financials

ARGQ Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Pacific Ventures (PACV) 0 25% -3.8 -65% 1,799 5,073 3,514 883 -1,171 -615 2,318
Galileo Acquisition (GLEO)
Gafisa (GFA)
VNUE (VNUE) 0 0% -2.0 -621% 168 3,666 200 0 -1,042 -634 1,242
New You (NWYU)
Angiosoma (SOAN) 0 64% -0.2 -475% 142 828 0 0 -675 -315 66
YaSheng Group (HERB)
Sprout Social (SPT)
Force Protection Video Equipment (FPVD) 0 56% 0.0 -394% 204 583 216 120 -802 -829 -1
United States Diesel-Heating Oil Fund (UHN) 0 0% -0.0 0 0 677 0 639 639 -0
FS Investment (FSIC)
XsunX (XSNX) 0 47% 0.1 1,089% 215 2,451 1,609 753 2,344 2,417 194
Nate's Food (NHMD) 0 92% -0.1 -6,857% 7 825 3 3 -481 -455 30
Crescent Acquisition Corp (CRSAU)
iGambit (IGMB) 0 -64% 0.0 -108% 2,105 1,465 21 -13 -2,269 -1,859 -10
Argentum 47 (ARGQ) 0 0% 0.0 -85% 1,487 2,005 87 0 -1,268 -1,187 -3
Regen Biopharma (RGBP) 0 0% -0.3 -4,777% 114 12,900 82 0 -5,461 -5,186 1,325
Kura Sushi (KRUS)
GH Capital (GHHC) 0 66% -0.0 -2,680% 89 331 211 139 -2,374 -2,374 59
Anchiano Therapeutics (ANCN)

Balance Sheet ($'000)2012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash732541049017192114256151567156115723761941273
Accounts Receivable28301450003333330060765222856013140611814787
Inventory
PP&E666587223029262320181512107532663837544
Assets1,320223318183268126556495568811029471,5972,8073,2663,2423,2163,2283,2173,0622,9832,0802,5033,8784,8982,1561,2909531,487
Accounts Payable70262451918310359496410189140637474
Long-Term Debt
Liabilities8428801,0866328409151,9772,1182,5452,9033,5043,9001,6462,2842,2302,0161,7441,8151,9431,3531,1791,3711,6711,9622,2362,7342,3241,7632,005
Stockholders' Equity477-657-767-928-1,052-1,269-2,441-2,643-2,997-3,842-4,423-2,953-495231,0361,2261,4721,4141,2731,7091,8047098321,9162,662-578-1,034-809-518
Income Statement ($'000)2012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue10816200701652152209-40151,1401,1301,027844262307010711010-2406137342924
Cost of Revenue
Gross Profit
R&D
SG&A247231375367539924545130888452622565648334656652642475849524061
Tax00000000000000000000000000
Net Income-139-1,192-1,510-361284-243-1,194-223-357-1,358-796373233438488-161-65-278-369-383-1,539-1,4201222,426743-975-568275
Cash Flow ($'000)2012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-32-42-0-93-36-801-4938329-44-1054610-136-125-172-112-27-25-130-278-175-130-180-56-40
Cash Investing-600-30-15-1000-000-100-152-4-1-102-10-1
Cash Financing3721590358520-367-4343106-6595125225601832712834060103720